|
CH583232A5
(GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
*
|
1973-02-02 |
1976-12-31 |
Wander Ag Dr A |
|
|
US3907819A
(en)
*
|
1973-05-14 |
1975-09-23 |
Du Pont |
Perhalogenated thiazoles
|
|
GB1560084A
(en)
*
|
1976-12-31 |
1980-01-30 |
Science Union & Cie |
Disubstituted piperazines processes for their preparation and pharmaceutical mompositions containing them
|
|
OA06083A
(fr)
*
|
1977-11-09 |
1981-06-30 |
Science Union & Cie Ste Franca |
Nouvelles pipérazines disubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant.
|
|
DE2961406D1
(en)
*
|
1978-04-13 |
1982-01-28 |
Science Union & Cie |
Monosubstituted piperazines, processes for their preparation and pharmaceutical compositions containing them
|
|
US4411900A
(en)
*
|
1980-01-03 |
1983-10-25 |
Fujisawa Pharmaceutical Co., Ltd. |
Benzhydrylpiperozinyl thiazole derivatives and pharmaceutical composition comprising the same
|
|
US4647557A
(en)
*
|
1982-12-28 |
1987-03-03 |
Gerard Moinet |
Novel heterocyclic derivatives bearing an amino radical, processes for their production and the pharmaceutical compositions containing them
|
|
HUT43600A
(en)
*
|
1985-06-22 |
1987-11-30 |
Sandoz Ag |
Process for production of new thiazole derivatives and medical compound containing those
|
|
US4914112A
(en)
*
|
1986-06-03 |
1990-04-03 |
Sumitomo Pharmaceuticals Company, Limited |
Aminoazole derivatives and their production and use
|
|
DE3812755A1
(de)
*
|
1988-04-16 |
1989-10-26 |
Merck Patent Gmbh |
Salicylsaeurederivate
|
|
FR2637596B1
(fr)
*
|
1988-10-11 |
1992-09-04 |
Irceba |
Methyl-4 ((aryl-4 piperazinyl-1)-2 ethyl)-5 thiazole et ses derives, leur procede de preparation et les medicaments en contenant
|
|
ES2062940B1
(es)
*
|
1993-03-11 |
1995-06-16 |
Vita Invest Sa |
Agente gastrocinetico, proceso para su preparacion y composiciones farmaceuticas que lo contengan.
|
|
TW200826936A
(en)
*
|
2006-12-01 |
2008-07-01 |
Merck Frosst Canada Ltd |
Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
WO2016030443A1
(en)
|
2014-08-28 |
2016-03-03 |
Asceneuron Sa |
Glycosidase inhibitors
|
|
US11612599B2
(en)
*
|
2016-02-25 |
2023-03-28 |
Asceneuron Sa |
Glycosidase inhibitors
|
|
IL260638B2
(en)
|
2016-02-25 |
2025-01-01 |
Asceneuron S A |
Acidic addition salts of piperazine derivatives
|
|
US11261183B2
(en)
|
2016-02-25 |
2022-03-01 |
Asceneuron Sa |
Sulfoximine glycosidase inhibitors
|
|
CA3012624A1
(en)
|
2016-02-25 |
2017-08-31 |
Asceneuron S.A. |
Glycosidase inhibitors
|
|
MA47575A
(fr)
*
|
2016-12-16 |
2020-01-01 |
Janssen Pharmaceutica Nv |
Composés inhibiteurs d'oga monocyclique
|
|
AU2017400271B2
(en)
*
|
2017-02-24 |
2020-09-24 |
Asceneuron S.A. |
Sulfoximine glycosidase inhibitors
|
|
US11458140B2
(en)
|
2017-08-24 |
2022-10-04 |
Asceneuron Sa |
Annulated glycosidase inhibitors
|
|
US11213525B2
(en)
|
2017-08-24 |
2022-01-04 |
Asceneuron Sa |
Linear glycosidase inhibitors
|
|
BR112021003022A2
(pt)
|
2018-08-22 |
2021-05-11 |
Asceneuron Sa |
sais de adição de ácido de ácido succínico ou ácido fumárico, de ácido monossuccínico, de ácido monofumárico e de adição de ácido succínico ou sal de adição de ácido fumárico, métodos para preparar um sal de adição de ácido do ácido succínico ou ácido fumárico, para tratar uma tauopatia e para inibir uma glicosidase, e, forma de dosagem oral sólida
|
|
US12016852B2
(en)
|
2018-08-22 |
2024-06-25 |
Asceneuron Sa |
Pyrrolidine glycosidase inhibitors
|
|
US11731972B2
(en)
|
2018-08-22 |
2023-08-22 |
Asceneuron Sa |
Spiro compounds as glycosidase inhibitors
|
|
WO2020039028A1
(en)
|
2018-08-22 |
2020-02-27 |
Asceneuron S. A. |
Tetrahydro-benzoazepine glycosidase inhibitors
|
|
US20220143042A1
(en)
|
2019-02-22 |
2022-05-12 |
Asceneuron Sa |
Fused glycosidase inhibitors
|